Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Bumetanide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Bumetanide 1mg tablets
0202020D0AAAEAE
|
Bumetanide | Bumetanide | Cardiovascular System | 216,059 |
|
Bumetanide 5mg tablets
0202020D0AAAFAF
|
Bumetanide | Bumetanide | Cardiovascular System | 4,419 |
|
Bumetanide 1mg/5ml oral solution sugar free
0202020D0AAADAD
|
Bumetanide | Bumetanide | Cardiovascular System | 498 |
|
Bumetanide 2mg/4ml solution for injection ampoules
0202020D0AAABAB
|
Bumetanide | Bumetanide | Cardiovascular System | No data available |
|
Bumetanide 5mg/5ml oral suspension
0202020D0AAAGAG
|
Bumetanide | Bumetanide | Cardiovascular System | No data available |
|
Burinex 1mg tablets
0202020D0BBAAAE
|
Burinex | Bumetanide | Cardiovascular System | No data available |
|
Burinex 5mg tablets
0202020D0BBABAF
|
Burinex | Bumetanide | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.